2007 G8 Summit Magazine - (Page 53) More than 450,000 people develop this dreaded disease every year. Families in developing nations often face the toughest challenges. Answers That Matter – Anywhere in the World ©2007 Eli Lilly and Company. MDR-TB knows no boundaries Deepening our commitment to fight MDR-TB At Lilly, we know what it takes to help families deal with many of the world’s most daunting health challenges. Multidrug-resistant tuberculosis is an example: it is highly contagious, tough to treat, and a growing threat to public health in countries around the world. Lilly is investing $120 million to fight MDR-TB with long-term, sustainable initiatives. We intend to help stop the spread of this killer wherever it may go – because people living with MDR-TB deserve this kind of answer every day. www.lillymdr-tb.com http://www.lillymdr-tb.com http://www.lillymdr-tb.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.